Koers NeuroOne Medical Technologies Corporation
Aandelen
NMTC
US64130M2098
Geavanceerde medische apparatuur & technologie
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
1,13 USD | +1,80% | -1,74% | -28,48% |
Omzet 2022 | 2,12 1,98 | Omzet 2023 | 3,41 3,19 | Marktkapitalisatie | 21,3 mln. 19,92 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -10 mln. -9,35 mln. | Nettowinst (verlies) 2023 | -11 mln. -10,29 mln. | EV/omzet 2022 | 7.761.717 x |
Nettoliquiditeiten 2022 | 10,94 mln. 10,23 mln. | Nettoliquiditeiten 2023 | 5,14 mln. 4,81 mln. | EV/omzet 2023 | 4.742.168 x |
K/w-verhouding 2022 |
-2,7
x | K/w-verhouding 2023 |
-1,36
x | Werknemers | 16 |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 87,9% |
Recentste transcriptie over NeuroOne Medical Technologies Corporation
1 dag | +1,80% | ||
1 week | -1,74% | ||
Lopende maand | -5,83% | ||
1 maand | -6,22% | ||
3 maanden | -9,24% | ||
6 maanden | +15,91% | ||
Lopend jaar | -28,48% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Mark Christanson
FOU | Founder | 56 | 20-08-09 |
David Rosa
CEO | Chief Executive Officer | 59 | 20-07-17 |
Ronald McClurg
DFI | Director of Finance/CFO | 65 | 01-01-21 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Paul Buckman
CHM | Chairman | 68 | 04-08-17 |
Director/Board Member | 63 | 04-08-17 | |
Edward Andrle
BRD | Director/Board Member | 66 | 18-02-20 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
26-04-24 | 1,13 | +1,80% | 59 275 |
25-04-24 | 1,11 | -4,31% | 38 572 |
24-04-24 | 1,16 | +1,75% | 525 154 |
23-04-24 | 1,14 | 0,00% | 52 236 |
22-04-24 | 1,14 | -0,87% | 72 192 |
uitgestelde koers Nasdaq, 26 april 2024 om 22:30 uur
Meer koersenVaira. 1 jan. | Kapi. | |
---|---|---|
-28,48% | 29,3 mln. | |
-12,91% | 19,08 mld. | |
-46,21% | 2,65 mld. | |
+18,15% | 1,87 mld. | |
-3,12% | 1,61 mld. | |
+23,78% | 1,21 mld. | |
-10,69% | 1,02 mld. | |
-20,89% | 905 mln. | |
-7,14% | 716 mln. | |
-18,10% | 682 mln. |